SARS CoV 2 News and Research

RSS

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

In a new study, researchers established a strong approach for deducing public health-relevant epidemiological metrics like relative variant abundance and variant-specific reproduction numbers from wastewater (WW)-derived deep sequenced SARS-CoV-2 genomes.

18 Jan 2022

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

In a new study, a team of researchers compared the severity of the SARS-CoV-2 Omicron variant to the Delta variant using the PCR proxy marker of RNA dependent RNA polymerase target delay.

18 Jan 2022

Exploring the viral dynamics of SARS-CoV-2 Omicron variant

In a new study, researchers posted findings in which they investigated the viral dynamics of the SARS-CoV-2 Omicron variant.

18 Jan 2022

Dynamics of outbreaks of SARS-CoV-2 variants of concern

In a new study, researchers characterized the features of the outbreak duration of the novel SARS-CoV-2 variants of concern.

18 Jan 2022

Direct effect of SARS-CoV-2 on the kidney

Researchers infected human-induced pluripotent-stem-cell (iPSC)-derived kidney organoids with SARS-CoV-2 to study the virus's direct effect on the kidney.

18 Jan 2022

Exploring the waning effect of mRNA vaccines against COVID-19 in the elderly

In a new study, researchers determined the vaccine effectiveness against SARS-CoV-2 in older individuals.

18 Jan 2022

SARS-CoV-2 protein biosensor employing colloidal quantum dots-modified electrode

An all-solid-state SARS-CoV-2 protein biosensor using lead sulfide colloidal quantum dots--modified electrode is demonstrated in this study by a group of researchers from several institutions.

18 Jan 2022

Study shows several low- and middle-income countries at over 50% risk of undetected Omicron transmission

In a new study, researchers estimated the probability of undetected emergence of the SARS-CoV-2 Omicron variant in 25 low and middle-income countries by early December 2021.

18 Jan 2022

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

Forecasting the temporal evolution of Omicron infections

In a new study, researchers estimated the rate of SARS-CoV-2 Omicron infections by modeling temporal evolution of the Omicron wave.

18 Jan 2022

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

In a new study, researchers analyzed the neutralization of SARS-CoV-2 Omicron and D614G variants before and after subjects received COVID-19 booster vaccinations.

18 Jan 2022

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

The authors highlight that they have shown that boosted individuals are significantly more protected against SARS-CoV-2 infection than any other group

18 Jan 2022

Antibody responses to COVID-19 mRNA vaccines in a cohort of healthcare workers

Researchers have been investigating the vaccine response of healthcare workers from specific vaccines to different variants.

18 Jan 2022

Researchers report isolation of potently neutralizing antibodies against highly transmissible SARS-CoV-2 variants

A recent preprint discusses using a combinatorial phage-display library approach to COVIID-19 antibodies.

18 Jan 2022

Machine learning model for prediction of COVID-19 patient mortality risk

A new preprint reports a novel machine learning model that purportedly predicts the mortality risk of COVID-19 in patients accurately and at an early stage of infection.

18 Jan 2022

Immune responses in Omicron breakthrough COVID-19

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

18 Jan 2022

Gaseous ozone is effective for SARS-CoV-2 disinfection

In their recent study published in the Journal of Hazardous Materials, researchers from the United Kingdom have found that ozone as a disinfectant is effective for the inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in liquid cell culture media as well as adhered on surfaces.

18 Jan 2022